About NEOMED-LABS
NEOMED-LABS is a Healthcare company based in Laval (Canada) founded in 2015, and was acquired by Ampersand Capital in September 2018. Contract research organisation offering immunology services for vaccines and immunotherapies. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.
Company details
NEOMED-LABS was established in 2015 and is headquartered in Laval, Canada. Contract research services in immunology are offered, with a focus on vaccines and immunotherapies within the biotechnology sector. Operations encompass preclinical studies, assay development, and support for therapeutic advancements. Expertise is applied to client projects in vaccine formulation and immunotherapy evaluation, ensuring compliance with regulatory standards in the pharmaceutical industry.
- Headquarters Laval, Canada
- Stage Acquired
- SectorsHealthcare
- Website neomedlabs.com
- Social LinkedIn
- Acquired by Ampersand Capital (Sep 2018)
- Investors
- Acquired byAmpersand Capital
(Sep 2018)
Investors in NEOMED-LABS
NEOMED-LABS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States |
Investor details for NEOMED-LABS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NEOMED-LABS
2 dated milestones of NEOMED-LABS across 3 years, from founding to its latest funding, stage changes and deals.
- Founded NEOMED-LABS is founded.
- Exit Acquired by Ampersand Capital.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neomed-Labs
Complete news archive for NEOMED-LABS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NEOMED-LABS
NEOMED-LABS was founded in 2015.
NEOMED-LABS is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
NEOMED-LABS was established in 2015 and is headquartered in Laval, Canada. Contract research services in immunology are offered, with a focus on vaccines and immunotherapies within the biotechnology sector. Operations encompass preclinical studies, assay development, and support for therapeutic advancements. Expertise is applied to client projects in vaccine formulation and immunotherapy evaluation, ensuring compliance with regulatory standards in the pharmaceutical industry.
NEOMED-LABS has 1 investor. Key investors include Ampersand Capital Partners.
Yes. NEOMED-LABS was acquired by Ampersand Capital in September 2018.